U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
112801112801A Pilot Open-label Randomized Study of Lactofiltrum in Women With Bacterial VaginosisRecruitingNo Results AvailableBacterial VaginosisDrug: Lactofiltrum + Metronidazole|Drug: Metronidazolehttps://ClinicalTrials.gov/show/NCT01089348
112802112802Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid NeoplasiaRecruitingNo Results AvailableThyroid Neoplasms|Thyroid CancerProcedure: Histological investigation of the SNhttps://ClinicalTrials.gov/show/NCT01089335
112803112803Risk Factors Associated to Difficult-to-control AsthmaCompletedNo Results AvailableAsthmaDrug: inhaled corticosteroid plus LABA plus oral corticosteroidhttps://ClinicalTrials.gov/show/NCT01089322
112804112804Effect of Aldosterone Blockade on Arterial ComplianceCompletedNo Results AvailableArterial Stiffness|Arterial ElasticityDrug: Spironolactonehttps://ClinicalTrials.gov/show/NCT01089309
112805112805The Norwegian Physical Therapy Study in Preterm InfantsActive, not recruitingNo Results AvailableMovement DisordersOther: Individually customized physiotherapyhttps://ClinicalTrials.gov/show/NCT01089296
112806112806Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic CharacteristicsNot yet recruitingNo Results AvailableParkinson Diseasehttps://ClinicalTrials.gov/show/NCT01089283
112807112807Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree RelativesNot yet recruitingNo Results AvailableParkinson Diseasehttps://ClinicalTrials.gov/show/NCT01089270
112808112808Cardiovascular Impairments and Obstructive Sleep Apnea SyndromeRecruitingNo Results AvailableSubclinical Cardiovascular Impairments|Obstructive Sleep Apnea Syndromehttps://ClinicalTrials.gov/show/NCT01089257
112809112809FET-PET for Diagnosis and Monitoring in Patients With Low Grade GliomaActive, not recruitingNo Results AvailableAstrocytoma|Oligoastrocytoma|Oligodendrogliomahttps://ClinicalTrials.gov/show/NCT01089244
112810112810Effects of Omega-3 Fatty Acids on the Human Gene ExpressionCompletedHas ResultsHyperlipidemia|HealthyDietary Supplement: Fish oil|Dietary Supplement: Placebo (corn oil)https://ClinicalTrials.gov/show/NCT01089231
112811112811The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum CytokinesCompletedNo Results AvailableFever|PneumoniaDrug: oral amoxicillin/clavulanate 1g (875/125mg)|Drug: controlhttps://ClinicalTrials.gov/show/NCT01089218
112812112812Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions.CompletedNo Results AvailableType 2 DiabetesDrug: Metforminhttps://ClinicalTrials.gov/show/NCT01089205
112813112813Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fasting Conditions.CompletedNo Results AvailableType 2 DiabetesDrug: Metforminhttps://ClinicalTrials.gov/show/NCT01089192
112814112814Bioequivalence Study of Metformin Hydrochloride Extended Release 500 mg Tablet Versus Glucophage XR® 500 mg Tablet in Healthy Volunteers Under Fed ConditionsCompletedNo Results AvailableType 2 DiabetesDrug: Metforminhttps://ClinicalTrials.gov/show/NCT01089179
112815112815Study to Compare the Bioavailability of Extended Release Metformin HCl Tablet Versus Glucophage XR® Tablets in Healthy Human Volunteers Under Fasting ConditionCompletedNo Results AvailableType 2 DiabetesDrug: Metforminhttps://ClinicalTrials.gov/show/NCT01089166
112816112816Obtaining and Storing Human Blood, Urine, and Fecal Samples for Spirochete-Related Epidemiological ResearchCompletedNo Results AvailableThe Samples Will be Studied in Order to Attempt to Better Understand the Occurrence of Blood, Feces and Urine Borne Spirochaeteshttps://ClinicalTrials.gov/show/NCT01089153
112817112817Non-Idiopathic Scoliosis Treated With Tranexamic AcidSuspendedNo Results AvailableNon-idiopathic ScoliosisDrug: Tranexamic acid 10mg/kg/hr|Drug: Tranexamic acid 100 mg/kg/h infusion|Drug: Saline solutionhttps://ClinicalTrials.gov/show/NCT01089140
112818112818Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedHas ResultsChronic Obstructive Pulmonary DiseaseDrug: Indacaterol|Drug: Salmeterol 50 μg|Drug: Placebo to indacaterol|Drug: Placebo to salmeterolhttps://ClinicalTrials.gov/show/NCT01089127
112819112819Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of PathophysiologyCompletedNo Results AvailableHIV|Cardiovascular Diseasehttps://ClinicalTrials.gov/show/NCT01089114
112820112820Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade GliomaRecruitingNo Results AvailableGlioma|Neurofibromatosis Type 1|Recurrent Childhood Pilocytic Astrocytoma|Recurrent Childhood Visual Pathway GliomaOther: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Selumetinibhttps://ClinicalTrials.gov/show/NCT01089101
112821112821Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the UrotheliumActive, not recruitingNo Results AvailableBladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral CancerDrug: cisplatin|Drug: gemcitabine hydrochloride|Drug: sunitinib malatehttps://ClinicalTrials.gov/show/NCT01089088
112822112822Neuropsychological Effects of Hydrocortisone in Patients With Partial Adrenal InsufficiencyTerminatedNo Results AvailablePartial Corticotrope InsufficiencyDrug: Hydrocortisone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01089075
112823112823Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial PressureCompletedHas ResultsHealthyDrug: MAP0004|Drug: IV Placebo (Saline)|Drug: Placebo Inhaler|Drug: IV Dihydroergotamine Mesylate (DHE)https://ClinicalTrials.gov/show/NCT01089062
112824112824Effect of a Natural Health Product on Urinary Estrogen MetabolitesCompletedNo Results AvailableBreast CancerDietary Supplement: FemMED Breast Health Formulahttps://ClinicalTrials.gov/show/NCT01089049
112825112825Oxidant-antioxidant Activity, Free Radicle Activity, Immune Response and Biomarkers in Extracorporeal Membrane Oxygenation (ECMO) PatientsRecruitingNo Results AvailableCardiogenic Shock|Acute Myocardial Infarction|Myocarditis|Cardiomyopathyhttps://ClinicalTrials.gov/show/NCT01089036
112826112826A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedHas ResultsRheumatoid ArthritisDrug: tocilizumab [RoActemra/Actemra]https://ClinicalTrials.gov/show/NCT01089023
112827112827A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNo Results AvailableAmyotrophic Lateral SclerosisDrug: Placebo|Drug: 250 mg CK-2017357|Drug: 500 mg CK-2017357https://ClinicalTrials.gov/show/NCT01089010
112828112828Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the NewbornTerminatedNo Results AvailablePersistent Pulmonary Hypertension of Newborn (PPHN)Drug: milrinone lactatehttps://ClinicalTrials.gov/show/NCT01088997
112829112829Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute LeukemiaCompletedHas ResultsLeukemiaDrug: Bendamustinehttps://ClinicalTrials.gov/show/NCT01088984
112830112830Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel SyndromeCompletedNo Results AvailableIrritable Bowel SyndromeDietary Supplement: Duolac7S|Dietary Supplement: starchhttps://ClinicalTrials.gov/show/NCT01088971

* Görseller ve İçerik tekif hakkına sahip olabilir